NCT05587582Completed
Behavioral Parenting Skills As A Novel Target for Improving Pediatric Medication Adherence
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Studies 1 and 2
Source: ClinicalTrials.gov · Last updated 7 Feb 2025
Brief summary (registry, in English)
This study observes behavioral parenting skills to see whether it could be a novel target for improving pediatric medication adherence. This study may help researchers better understand the challenges parents face when giving their young child with an illness medicine at home and learn about various factors related to medication compliance in young children
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 51 (actual)
- First submitted
- 14 Oct 2022
- Start date
- 1 Sept 2022
- Primary completion date
- 7 Jan 2025
- Lead sponsor
- Roswell Park Cancer Institute
- Diseases
- Acute lymphoblastic leukaemia
- NCT number
- NCT05587582
What you commit to
- Study type: Observational
- Participants enrolled: 51
- From 1 Sept 2022 to the primary completion date, 7 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- INCLUSION:
- Parent of a child diagnosed within the past month with acute lymphoblastic leukemia (ALL)
- Pediatric patient's age 3 - 9.
- \* If present during the home visit, any other child, ages 0-18
- Child on therapy that includes oral mercaptopurine (6-MP) administration
- Parent age 18 - NA (No Limit)
- Parent should have verbal English fluency
- Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
- The following special populations may be included in this study:
- Pregnant women: due to the design of this behavioral research, pregnant and fetuses should incur no elevated risk from participation.
- Children under age 18 will participate in one aspect of the study, the video recording of medication administration.
- \* Other children (not the pediatric patient) under age 18 that are present during the time of the home visit
- Exclusion:
- Pediatric patient is on therapy that does not include oral 6-MP administration
- Cognitively impaired adults/adults with impaired decision-making capacity
- Pediatric patients who are not yet adults (infants under the age of 3, children over 9 years, teenagers)
- Prisoners
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Roswell Park Cancer Institute Coordinator of this site? Confirm its status | Buffalo | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.